/HFDQFHUGHODSURVWDWHUpVLVWDQWjODFDVWUDWLRQ
&35&PpWDVWDWLTXHDXFRQJUqVGHO·$)8
7%HVVHGH
D'·DSUqVOHVFRPPXQLFDWLRQVGHV3URIHVVHXUV%0DODYDXG
E6&XOLQH
F0=HUELE
GD6HUYLFHG·8URORJLH&+8%LFrWUHUXHGX*pQpUDO/HFOHUF/H.UHPOLQ%LFrWUH)UDQFH
E6HUYLFHG·8URORJLH+{SLWDOGH5DQJXHLODYHQXHGX3URIHVVHXU-HDQ3RXOKqV7RXORXVHFHGH[)UDQFH
F6HUYLFHG·2QFRORJLHPpGLFDOH*URXSH+RVSLWDOLHU6W/RXLV/DULERLVLqUH):LGDO3DULV)UDQFH
G6HUYLFHG·8URORJLH+{SLWDO&RFKLQ5XHGX)DXERXUJ6DLQW-DFTXHV3DULV)UDQFH
$GUHVVHHPDLO !"#
$% & '()("* &*
Les messages du congrès de l’AFU 2011
68953ISSN 1166- 7087
Numéro réalisé avec le soutien institutionnel des Laboratoires Takeda
/DUpVLVWDQFHjODFDVWUDWLRQ ,QWURGXFWLRQ
,*- * * * ./ **0 1 2* 3) 2) 4&*
5 * * & &
& 2) 66* 7 &
0 & 0
* .& 3 2)89 & 3*
: ; * 40 4 * .
9RLHJpQRPLTXHGX5$
< & &*
= 30* *=04.*
.* & &0 < *
6 & 70
* *7 * >?"@*
<>?"0 6 & " * 2)* 3 0 3 70 * 70 <
>?"2* 0* 7 7=
: 6 4)2%) 2 % 7 * 0* 89
< 3 >?"2* **4A 0 * *
9RLHVH[WUDJpQRPLTXHVGX5$
( *0 * 3
& * 2) &
* * % 66 04
*. 2)6*4
& * 3 *.
7* * "7 B &* *."7 B * & &
2) *
*0 * &
2) & 3*0 <&
2) 5 &* &* * EFC6 7 G *10 40 0
*0 E * 0 & 2) * 6* 4 5 &* . 6 70 89
%H 3* &
*& 0 3 2)* * * .8-9>
2) * 0 & 4&* 4*
4 & &*8-9 1
* * 2)
0RGLÀFDWLRQGX5$
> 2) 40 * .%1 2) ; .6 &
& *
* 3 ) 2)8H9 4 * * 1 2)0 &
* & 30 7 8-@9> * 1 6 41*0 & 1 & 2) * . 89<* 4 4 3&
0 0 5 *I 6 J 6 4
<4* & 7 . * *& : * K7 . * I 0 8M9 *461
*0 ** *& K
* . K 0 34
* *0 66 3* 8O9
1RXYHOOHFLEOHWKpUDSHXWLTXH
<4* 6. *YLD-6 6* & 7 0 .7
>*?7" * 6 &
P4 >?%) * 4) & 6 &
QO 6 7 H@ 6 K70 89P 0 7 * QO .4 66 7 4
=8D9E6* 0 QO &
7 *I *I *I &
*I 3 *: 64)"?
0 & & **I <
4* 4 * 5 * I & *I *& * * 47G* > * *& **1 4* 4
* .6 K * *3 K I68D9
&RQFOXVLRQ
) & 3*0 2) *. *0 7 4 &
1* * .
<4* 4 * & 7
/HVRSWLRQVWKpUDSHXWLTXHV ,QWURGXFWLRQ
> & * .*
6 * * * & * 366* * * =
2SWLRQVDFWXHOOHV
< 2 *=04.1 * 0 * 0 * *
% *0 .6& *10 0 *0 )*** &
H0 4 K*0 * *&* 3 0 4*3 R & 89
;* * * 0 2 0 2*0 7 0 2*0 70 2 *3 % * 0 * .4
*0 0 * * **
,PPXQRWKpUDSLH
A * **** 42
*0 % 4& 3&&
* 4 & * 6* F7 ' (CE44
* &* 4
& -= .@=4 & )&
& H K@
*0 2** 4
* *5* 0 **89
& & M K S* O@(
&***%,FU **14 & 16<47 *& 3 * () -U * 4 * & @U VHU4*
0* & & -UV@U 6 & HUV< & 4*&*
* * 044 *&* 3HU& HHU7 .45 U& HU*
-U& MU 1 3*
4* 4 * ** 0
& *10 ** * --U
& HU 47G* U& DU0 * ) . 0 4* 4 * 3 4 3** 1& 61 04 K 2
*0 * 4 *3
/·DFpWDWHG·DELUDWpURQHHQSUDWLTXH
<4* 4 * W ) ' '* 4* *3
< * &* 3 * 3* * * & 4 < **
0 &*1 *0 G*
6 *0 < = 4 =H* @ .X=
14*& *: 64)"?
(4& 0 0 /
Y 0 * J * . Y 0 G* *0
-
A * 0 47G* Z &
.@X=5 * 77 .@[
5*16 &* 77 .[E47 4 .6* 3 * &
& \3 * 6 &
Q>M Q-)H 0 & 6 &
0
&RQFOXVLRQ
< 4* 4 * 4 4 * *I 4 & *0 G*0
/HIXWXUGDQVOH&53&
* *& &
2 * ( 4 ** **
6 * ] &D 60 4)''4 C
&KLPLRWKpUDSLHGHGHX[LqPHOLJQH
A 3 * & 4*
"2,E0 4 K3 K & 2*0 *3 8-9< K3
* 3 ** *0
*3 6 61* 77*
% 6 4 1 * 66*
*3 4 *
*** < & ****
.3 * H3
= 3* * *
1RXYHOOHKRUPRQRWKpUDSLH
A * 0 -*&*
* & D@ * 0 *0 * .8H9
< * * &
. 4*
4 * =& <
4*&*&
* *& 0
& 3 * ()0*
& 6 A * &
O@U %,F.U
*0 *0 U>OU 4& W04 * )&
7 * 8H9 7 1 8@9 & H
** *& & ?K 2.OHVC%7 1*
& * *& 4S
A Overall Survival
Survival (%) Abiraterone
acetate
Abiraterone acetate
Placebo 797 736 657 520 282 68 2 0
398 355 306 210 105 30 3 0
0 3 6 9 12 15 18 21
Months No. at Risk
0 20 40 60 80 100
Placebo
)LJXUH (& )* 4 * 8@9
* .8D9<4 6 6 52).&
* 0 *'>^-<&
4)>[ 4 3 ***
* <4*5 *0 '>^- 4&
61* 2)6 0 0 &* * <4* )CCE2' 0 * * 4 66 '>^- K ***3 89
&RQFOXVLRQ
> & * 0 . 66* *& 2(
4*
6 47 0 6
* * 3 & * & 3 * * & 3 4*0 &
* 0 2
5pIpUHQFHV
89 B?(Q( 6' <C) ' 76 2 ZM-/-M--
89 # [F 2)? _>_>`F F ' 76 E_
# #ZHM/-O
8-9 >` >("# G(? 2^ 2 ' 6 7[' HZ/--D
8H9 F %' 76 _ ,Z-/-@
8@9 (%_(&(" ff7
%3 6 f
& DD@ZOM/H-H 8M9 >2<'CB())
0 6 7 K 6 ' % ZD@/@
8O9 "')( '_<C#" B#' _<"
7 &
2 @Z-/HM@-O
89 <G _)F%(< G)))??? 7(`
) ) & 7 &
6 2 ZM@/MHO@
8D9 27_('2C<2 _%B6627 C E6 QO &7 f f & G K 7_,ZD/H
89 ( C F >' '7 2" G 7 ( ^
< < )K 6 K f 67 _[ EZDHD/H@M 89 "G EC ` 2 # 7 `2 ? _ KG)
B[ > 3 3 6 & [ % _ ' HZ-@@/@
5DGLRSKDUPDFHXWLTXH
<4 2- 0 5 *0 **
0 *6 6 61* 3.4 3 &
0 & 3 0 *0
**** * -0 *&
& K * g1h4 * 3 & * 8M9E44 &* 0 & =1* : 4 7 * < ?K 2 * OV@ 3** * 7 3*
*0
5LVTXHRVVHX[
%70 4 & 2)[B2)[B
<4*** * * * < * 4 4*** & *
& > 3* - *&
*6& * 2
> * K *0 3 -4 *&*
3** &*.
K*0 8O9A * K
*0 .0 3()j V& *
*** H*
. 89> *& * * ** ; 42
7KpUDSLHVFLEOpHV
< * * *
*&* 2 K 0 '%" ^%FC26 4 = 4 * *&
K 2%E("0 K * 3 * > * 6
* * 4*&
4 3 * - * 0 2
1RXYHDX[DQWLDQGURJqQHV
<4'>^-*** . 4
** 4 66 4 2)5 4 3*
) 6 f 7 2/) - )<(Q')E/
%(',ZZ(GZ
8O9 CKK B ' ( ' > 2 #f _ B
< > & K 6 6 f / 7 <
Z-OODOM/-
89 ('2(C 2( [CKKB" #
> 6 && f / 6 - < Z-ODD/-DHM 8D9 ",G( [_ Q`))^
> & 6 6 6& ( DZ-H@D/OOD 89 7G>
A2 Z-/O-D 89 B66`?(( [># %2(%_
>C ( " 76 [%_' Z-M-@/H
8-9 #_(,(,K'? (' _ BGE K3 3 6 6 3 /
< Z-OMDOHO/HO@H
8H9 #_(< _')CKKB[(<
) &&
[%_' Z-MH/DD@@
8@9 CKKB( ?E')C,& (&&,()7 6,A))- -(76) ) `' 2 2 `> 3 E/%(',Z Z(GZ) pO
8M9 G ? > ,4(& _' C ( G)
> Gf " ,& && 1 6 2-